Galaxa Pharma a/s: Financial statements 2021
CVR: 41183144
Source: annual report 2021, Danish Business Authority
01/10/2020 – 30/09/2021
Galaxa Pharma a/s (CVR 41183144) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 666,300 and a net result of DKK -133,658. The profit margin was -20.1%. Equity in the 2021 report amounted to DKK 360,227. The solvency ratio was 10.7%. The company had 1 employee in the financial year.
- Revenue
- DKK 666,300
- Gross Profit
- DKK -6,034
- Profit/Loss
- DKK -133,658
- Equity
- DKK 360,227
- Total Assets
- DKK 3,380,183
- Employees
- 1
Official annual report
Find more companies like Galaxa Pharma a/s
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of July 1, 2021, Gitte Henriksen has joined the board of directors of Galaxa Pharma a/s.
As of July 1, 2021, Jørgen Flemming Ladefoged has joined the board of directors of Galaxa Pharma a/s.
As of June 30, 2021, Gitte Henriksen has left the board of directors of Galaxa Pharma a/s.
As of June 30, 2021, Jørgen Flemming Ladefoged has left the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Jørgen Flemming Ladefoged has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Anders Permin has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Stein Arve Løkstad has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Bo Erik Lennart Unéus has joined the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Lone Henriksen has left the board of directors of Galaxa Pharma a/s.
As of April 16, 2021, Simon Tønners has left the board of directors of Galaxa Pharma a/s.
About Galaxa Pharma a/s
Galaxa Pharma a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named CanNordic A/S. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -398,874 and a net result of DKK -461,281 compared with DKK -819,815 the year before. Equity in the 2025 report amounted to DKK -209,574.